Viking Therapeutics (VKTX) Leases (2019 - 2025)
Historic Leases for Viking Therapeutics (VKTX) over the last 7 years, with Q4 2025 value amounting to $85000.0.
- Viking Therapeutics' Leases fell 9152.54% to $85000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $85000.0, marking a year-over-year decrease of 9152.54%. This contributed to the annual value of $85000.0 for FY2025, which is 9152.54% down from last year.
- Viking Therapeutics' Leases amounted to $85000.0 in Q4 2025, which was down 9152.54% from $666000.0 recorded in Q3 2025.
- In the past 5 years, Viking Therapeutics' Leases ranged from a high of $1.6 million in Q1 2022 and a low of $25000.0 during Q4 2021
- For the 5-year period, Viking Therapeutics' Leases averaged around $908150.0, with its median value being $1.0 million (2024).
- In the last 5 years, Viking Therapeutics' Leases tumbled by 9221.18% in 2021 and then surged by 557200.0% in 2022.
- Viking Therapeutics' Leases (Quarter) stood at $25000.0 in 2021, then surged by 5572.0% to $1.4 million in 2022, then decreased by 20.59% to $1.1 million in 2023, then fell by 10.92% to $1.0 million in 2024, then tumbled by 91.53% to $85000.0 in 2025.
- Its Leases was $85000.0 in Q4 2025, compared to $666000.0 in Q3 2025 and $780000.0 in Q2 2025.